Keyphrases
Pediatric
100%
Familial Mediterranean Fever
90%
Familial Mediterranean Fever Patient
37%
Colchicine
33%
Canakinumab
31%
Interleukin-1β
27%
Autoinflammatory Diseases
26%
Working Diagnosis
25%
Bleeding
25%
Colchicine Treatment
24%
Systemic Juvenile Idiopathic Arthritis (sJIA)
24%
Colchicine Resistance
23%
Arthritis
22%
Deficiency Cases
22%
Autoimmune Inner Ear Disease
22%
Heterozygous Variant
22%
Myalgia
22%
Treating children
22%
Protracted Febrile Myalgia
22%
E148Q
22%
Bleeding Symptoms
22%
Colchicine-resistant Familial Mediterranean Fever
22%
Immune Thrombocytopenia
22%
Clinical Significance
22%
Childhood Immune Thrombocytopenia
22%
Post-streptococcal
22%
On Demand
22%
Granulomatosis with Polyangiitis
22%
Peripartum Hemorrhage
22%
Peripartum
22%
Gaucher Disease
22%
Pyoderma Gangrenosum
22%
Platelet Function
22%
Older Adults
22%
Intolerant
22%
Adherence to Medication
22%
Interleukin-1 Antagonist
22%
Child Growth
22%
Childhood-onset Systemic Lupus Erythematosus
22%
M694V
21%
Systemic Lupus Erythematous
18%
Non-adherent
18%
IL-1 Blocking Agents
17%
Clinical Characteristics
15%
Non-adherence
14%
Platelets
12%
Rheumatic Diseases
11%
Immune Dysregulation
11%
Common Variable Immune Deficiency
11%
Hearing Impairment
11%
Medicine and Dentistry
Bleeding
44%
Pediatrics
44%
Symptom
36%
Familial Mediterranean Fever
25%
Arthritis
22%
Inner Ear Disease
22%
Myalgia
22%
Idiopathic Thrombocytopenic Purpura
22%
Venous Ulcer
22%
Thrombocyte Function
22%
Canakinumab
22%
Gaucher's Disease
22%
Granulomatosis with Polyangiitis
22%
Pyoderma gangrenosum
22%
Colchicine
22%
Platelet
14%
Juvenile Idiopathic Arthritis
13%
Hearing Impairment
11%
Diagnosis
11%
Rheumatic Disease
8%
Common Variable Immunodeficiency
8%
Immune Dysregulation
8%
Function Test
8%
Drug Therapy
7%
Vasculitis
7%
Clinical Feature
6%
Immunosuppressive Drug
6%
Cyclosporine
6%
Case Presentation
6%
Ulcer
6%
Disease
5%
Autoantibodies
5%
Cochlear Implantation
5%
Sensorineural Hearing Loss
5%
Immunosuppressive Treatment
5%
Combination Therapy
5%
Injury
5%
Pharmacology, Toxicology and Pharmaceutical Science
Colchicine
88%
Familial Mediterranean Fever
88%
Bleeding
44%
Canakinumab
28%
Symptom
24%
Arthritis
22%
Systemic Lupus Erythematosus
22%
Idiopathic Thrombocytopenic Purpura
22%
Gaucher's Disease
22%
Interleukin 1 Receptor Blocking Agent
22%
Disease
18%
Juvenile Rheumatoid Arthritis
13%
Immune Dysregulation
8%
Rheumatic Disease
8%
Common Variable Immunodeficiency
8%
Mycophenolic Acid
7%
Remission
6%
Clinical Feature
6%
Anakinra
6%
Adverse Event
5%
